TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Novartis Norge AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
110,340
|
135,184
|
130,840 |
Financial expenses |
73
|
87
|
197 |
Earnings before taxes |
3,674
|
5,832
|
4,948 |
Total assets |
56,286
|
44,347
|
47,580 |
Current assets |
55,383
|
44,070
|
46,967 |
Current liabilities |
31,710
|
21,412
|
25,372 |
Equity capital |
24,543
|
22,890
|
17,414 |
- share capital |
142
|
150
|
143 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
43.6%
|
51.6%
|
36.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.3%
|
4.3%
|
3.8% |
Return on assets (ROA) |
6.7%
|
13.3%
|
10.8% |
Current ratio |
174.7%
|
205.8%
|
185.1% |
Return on equity (ROE) |
15.0%
|
25.5%
|
28.4% |
Change turnover |
-17,743
|
-2,764
|
-638 |
Change turnover % |
-14%
|
-2%
|
0% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.